Skip to search formSkip to main contentSkip to account menu

Beta Isomer of C-Terminal Telopeptide of Type I Collagen

Known as: Beta Isoform of the Cross-Linked C-Terminal Telopeptide of Type I Collagen, Beta Isoform of the Carboxy-Terminal Cross-Linking Telopeptide of Type I Collagen, Beta-C-Telopeptide of Type I Collagen 
This polypeptide is comprised of the proteolytically released carboxy-terminal portions of fibrillar type I collagen where age has converted the… 
National Institutes of Health

Related topics

Related topics

13 relations
Cell AdhesionCell MovementCollagen GeneExtracellular Matrix

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women
SummaryThe present cross-sectional study constructed reference ranges for bone resorption marker beta isomerized form of C… 
2014
2014
SAT0476 Vitamin D Supplementation in Liver Transplant Patients
Background Liver transplant patients are at risk of developing osteoporosis and vitamin D deficiency. This deficit can be… 
2011
2011
Correlation between the circulating bone markers and vitamin D in the healthy Thai people.
There are several circulating bone markers that are useful for physicians in determining the bone quality. The markers are… 
2011
2011
Osteoblastic functions: a lesson from biochemical bone markers.
The present study showed the lowest values of bone markers from osteoblast, NMID osteocalcin, 10.81 +/- 3.9 ng/ ml and PINP 15.88… 
2011
2011
Changes in serum levels of biochemical markers of bone turnover during 10 years among Japanese men and women: associated factors and birth-cohort effect. The Taiji Study
We aimed to clarify changes in biochemical markers of bone turnover (BTMs) over 10 years, associations with changes in bone… 
2009
2009
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours.
Zoledronic acid (Zometa, ZOL) is increasingly used to treat tumour-induced bone disease, and is also reported to have… 
2009
2009
Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
2007
2007
Lack of an acute effect of ghrelin on markers of bone turnover in healthy controls and post-gastrectomy subjects.
1999
1999
Urinary alpha and beta C-telopeptides of collagen I: clinical implications in bone remodeling in patients with anorexia nervosa.
Fragments derived from degradation of type I collagen C-telopeptide (CTX) can be nonisomerized (alpha) or beta-isomerized (beta… 
Highly Cited
1999
Highly Cited
1999
Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)